Related Experiment Video
Updated: Mar 18, 2026

Imaging the Intracellular Trafficking of APP with Photoactivatable GFP
Published on: October 17, 2015
Sorting Out Presenilins in Alzheimer's Disease
Michael S Wolfe1, Bruce A Yankner2
1Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA 02115, USA.
Familial Alzheimer's disease mutations in presenilins change protease activity. This study reveals that altered subcellular localization of presenilins is key to amyloid beta generation, advancing Alzheimer's disease cell biology understanding.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Familial Alzheimer's disease (AD) is linked to mutations in presenilin proteins.
- These mutations increase the production of aggregation-prone amyloid beta (Aβ) peptides.
- The precise mechanism by which presenilin mutations affect Aβ generation has remained unclear.
Purpose of the Study:
- To elucidate the mechanism by which presenilin mutations lead to increased amyloid beta (Aβ) generation in familial Alzheimer's disease.
- To investigate the role of subcellular localization in the altered protease activity of mutated presenilins.
Main Methods:
- Utilized cell-based assays to examine presenilin localization and activity.
- Investigated the impact of mutations on presenilin trafficking and function within the cell.
- Quantified amyloid beta (Aβ) peptide generation under different localization conditions.
Main Results:
- Presenilin mutations significantly alter the subcellular localization of these proteases.
- Changes in localization directly correlate with increased production of the aggregation-prone amyloid beta (Aβ) isoform.
- Subcellular trafficking is a critical regulatory step in presenilin-mediated Aβ production.
Conclusions:
- Regulation of subcellular localization is a central mechanism by which presenilin mutations drive amyloid beta (Aβ) pathology in familial Alzheimer's disease.
- This finding provides crucial insights into the cell biology of Alzheimer's disease and potential therapeutic targets.
More Related Videos
11:57Saccharomyces cerevisiae Models of Alzheimer's Disease to Screen Genes, Mutations, and Chemicals Affecting Amyloid Beta Production by γ-Secretase
Published on: June 24, 2025
14:57Preparation of Acute Hippocampal Slices from Rats and Transgenic Mice for the Study of Synaptic Alterations during Aging and Amyloid Pathology
Published on: March 23, 2011
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Alzheimer's Disease: Treatment